AES - DRS - Synexus Clinical Research US, Inc. - Birmingham

Birmingham, Alabama 35211-1320

1 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus, Type II Diabetes Mellitus

Studies at this site

• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Recruiting now
• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed